Review article: the economic impact of the irritable bowel syndrome

@article{Canavan2014ReviewAT,
  title={Review article: the economic impact of the irritable bowel syndrome},
  author={C. Canavan and J. West and T. Card},
  journal={Alimentary Pharmacology \& Therapeutics},
  year={2014},
  volume={40}
}
Irritable bowel syndrome (IBS) is a chronic functional disorder of the gastrointestinal system affecting a large number of people worldwide. Whilst it has no attributable mortality, it has substantial impact on patients' quality of life (QoL) and is associated with considerable healthcare resource use. 

Paper Mentions

Interventional Clinical Trial
This study will evaluate the impact of a Mediterranean-style diet on microbiome diversity compared to a typical American diet. The study will observe the microbiome composition… Expand
ConditionsIrritable Bowel Syndrome
InterventionOther
Interventional Clinical Trial
Irritable bowel syndrome (IBS) is a chronic disease characterized by the association of abdominal pain and transit disorders. IBS affects 5 to 10% of the population. There are… Expand
ConditionsIrritable Bowel Syndrome With Diarrhea
InterventionOther
Interventional Clinical Trial
IBS is a global disease, patients often because of long-term symptoms of recurrent, not timely diagnosis and treatment effect is not ideal and frequent treatment, seriously affect… Expand
ConditionsFood Habits
InterventionBehavioral
Irritable bowel syndrome: enigmatic for doctors, problematic for patients
TLDR
Although in Europe IBS more often presents in women, men also suffer and this potential diagnosis should not be overlooked. Expand
Managing the symptoms of irritable bowel syndrome
TLDR
Self-care in IBS is discussed, a common long-term illness that affects around 14% of the UK population and most patients with IBS are managed in primary care and seek help for continuing symptoms, yet IBS does not come under the Quality and Outcomes Framework. Expand
Systematic review with meta‐analysis: the prevalence of bile acid malabsorption in the irritable bowel syndrome with diarrhoea
TLDR
Previous studies support the proposal that a subset of patients with features compatible with diarrhoea‐predominant IBS (IBS‐D) have bile acid malabsorption (BAM). Expand
Systematic review with meta‐analysis: post‐infectious irritable bowel syndrome after travellers' diarrhoea
Gastrointestinal infection is known as a risk factor for the development of the irritable bowel syndrome (post‐infectious irritable bowel syndrome, PI‐IBS). The incidence of PI‐IBS ranges between 3%Expand
Vortioxetine effects on quality of life of irritable bowel syndrome patients: A randomized, double‐blind, placebo‐controlled trial
TLDR
This study investigates the effects of vortioxetine vs placebo in enhancing the IBS patients' quality of life and concludes that the former is more beneficial than the latter. Expand
Systematic review with meta‐analysis: the accuracy of diagnosing irritable bowel syndrome with symptoms, biomarkers and/or psychological markers
TLDR
It is necessary to select patients suitable for vaginal or laparoscopic mesh placement for IBS preoperatively on the basis of prior history and once they provide informed consent for surgery. Expand
Hypnotherapy for irritable bowel syndrome: an audit of one thousand adult patients
TLDR
Gut‐focused hypnotherapy improves the symptoms of irritable bowel syndrome (IBS) with benefits being sustained for many years and relatively small numbers in published studies. Expand
Exercise therapy of patients with irritable bowel syndrome: A systematic review of randomized controlled trials
TLDR
As drug use has limitations in the treatment of irritable bowel syndrome, increasing attention is being paid to nondrug therapies and complementary treatments, especially exercise, where the effects of exercise on IBS are unclear. Expand
Irritable bowel syndrome
TLDR
This review provides a focused summary of the epidemiology, clinical features, differential diagnosis and management of IBS. Expand
Are characteristics of abdominal pain helpful to identify patients with visceral hypersensitivity in irritable bowel syndrome? Results of a prospective study
TLDR
Assessment of characteristics of abdominal pain in IBS patients could be suggestive of hypersensitivity to determine whether patients with visceral hypersensitivity have a higher risk of developing IBS. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 69 REFERENCES
Clinical economics review: irritable bowel syndrome
TLDR
The ubiquitous nature of irritable bowel syndrome has created the impression that the condition must represent a large drain on health‐care resources, but the literature certainly appears to support this view but is largely based on patients seen in referral centres and it may not be appropriate to extrapolate these data to the IBS population as a whole. Expand
The economic impact of irritable bowel syndrome
Background : Although little mortality is associated with irritable bowel syndrome, curative therapy does not exist and thus the economic impact of this disorder may be considerable.
Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact
Background : The impact of irritable bowel syndrome, a gastrointestinal motility disorder, is underestimated and poorly quantified, as clinicians may see only a minority of sufferers.
Quality of Life and Illness Costs in Irritable Bowel Syndrome
TLDR
During a meeting in London, UK, the IBiS club reviewed the literature on quality of life and costs in patients with irritable bowel syndrome and the clinical and scientific relevance of the current knowledge was assessed. Expand
Costs of health care for irritable bowel syndrome, chronic constipation, functional diarrhoea and functional abdominal pain
Aim To provide estimates of actual costs to deliver health care to patients with functional bowel disorders, and to assess the cost impact of symptom severity, recency of onset, and satisfaction withExpand
The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjects
TLDR
To determine the prevalence, symptom pattern and impact of the irritable bowel syndrome, across eight European countries, using a standardized methodology, the aim was to establish a standard methodology and establish a baseline for this study. Expand
Patient‐perceived severity of irritable bowel syndrome in relation to symptoms, health resource utilization and quality of life
TLDR
The relationship between patient‐rated severity of IBS and patients' physical and psychological symptoms, health care resource use and quality of life are evaluated. Expand
Predictors of conventional and alternative health care seeking for irritable bowel syndrome and functional dyspepsia
TLDR
The drivers of conventional and, especially, alternative health care use for irritable bowel syndrome and functional dyspepsia are not clear and the need for further study is unclear. Expand
Health‐related quality of life among persons with irritable bowel syndrome: a systematic review
TLDR
A systematic review of the literature is performed to compare the health related quality of life of patients with irritable bowel syndrome with that of healthy controls and to examine therapy‐associated changes in HRQoL of irritated bowel syndrome patients. Expand
The validity and accuracy of the Work Productivity and Activity Impairment questionnaire – irritable bowel syndrome version (WPAI:IBS)
TLDR
This study presents a new treatment for irritable bowel syndrome with real-world implications for patients’ quality of life and productivity loss. Expand
...
1
2
3
4
5
...